End-of-day quote
Other stock markets
|
||
- | - |
2023 | Green Cross Health Limited Declares an Interim Dividend, Payable on 20 December 2023 | CI |
2023 | Green Cross Health Limited Reports Earnings Results for the Half Year Ended September 30, 2023 | CI |
Sales 2022 | 670M 397M 0 33.17B | Sales 2023 | 494M 293M 0 24.42B | Capitalization | 193M 115M 0 9.57B |
---|---|---|---|---|---|
Net income 2022 | 24M 14.23M - 1.19B | Net income 2023 | 45M 26.68M - 2.23B | EV / Sales 2022 | 0.39 x |
Net Debt 2022 | 72.29M 42.85M 0 3.58B | Net Debt 2023 | 64.6M 38.3M 0 3.2B | EV / Sales 2023 | 0.52 x |
P/E ratio 2022 |
7.78
x | P/E ratio 2023 |
4.29
x | Employees | - |
Yield 2022 |
4.89% | Yield 2023 |
5.19% | Free-Float | 21.74% |
Managers | Title | Age | Since |
---|---|---|---|
Rachael Newfield
CEO | Chief Executive Officer | - | 30/18/30 |
Kalpana Goundar
DFI | Director of Finance/CFO | 40 | 04/12 |
Gary Safe
CTO | Chief Tech/Sci/R&D Officer | - | 01/10/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Bagnall
BRD | Director/Board Member | - | 30/09/30 |
Kimmitt Ellis
CHM | Chairman | - | 02/19/02 |
Peter Merton
BRD | Director/Board Member | 61 | 30/09/30 |
1st Jan change | Capi. | |
---|---|---|
-12.99% | 8.47B | |
+38.91% | 1.33B | |
+7.91% | 421M | |
-2.57% | 292M | |
+10.56% | 224M | |
+23.75% | 60.96M |